These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7265986)

  • 1. Antipyrine estimations in the rabbit using gas--liquid chromatography: a reliable method for studying factors affecting oxidative drug metabolism.
    Chambers DM; Jefferson GC
    J Pharmacol Methods; 1981 Jan; 5(1):59-66. PubMed ID: 7265986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid gas-liquid chromatographic determination of antipyrine clearance in the rat.
    Knights KM; Gourlay GK; Adams JF; Cousins MJ
    J Pharmacol Methods; 1981 Mar; 5(2):121-5. PubMed ID: 7230835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple reversed-phase high-performance liquid chromatographic determination of antipyrine in rabbit plasma for pharmacokinetic studies.
    De Beer JO; Jacobs GA; Martens MA
    J Chromatogr; 1984 May; 307(2):475-80. PubMed ID: 6736197
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid gas-liquid chromatographic estimation of antipyrine in plasma.
    Prescott LF; Adjepon-Yamoah KK; Roberts E
    J Pharm Pharmacol; 1973 Mar; 25(3):205-7. PubMed ID: 4146319
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 8. A rapid and sensitive method for the determination of phenazone (antipyrine) using gas-liquid-chromatography with nitrogen detection.
    Staiger C; de Vries J; Walter E
    J Clin Chem Clin Biochem; 1980 Nov; 18(11):817-9. PubMed ID: 7441177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
    Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine plasma half-life. In vivo indicator of oxidative metabolic capability in Rhesus monkeys (Macaca mulatta).
    Miller JL; Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 16(5):279-86. PubMed ID: 417345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-pressure liquid chromatographic analysis of antipyrine in small plasma samples.
    Shargel L; Cheung WM; Yu AB
    J Pharm Sci; 1979 Aug; 68(8):1052-4. PubMed ID: 480161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of the antipyrine test for studying microsomal drug oxidation].
    Viktorov AP; Rybak AT
    Farmakol Toksikol; 1990; 53(1):74-7. PubMed ID: 2184052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antipyrine kinetics by measurement in saliva.
    Fraser HS; Mucklow JC; Murray S; Davies DS
    Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV; Abul-Hajj Y; Awni WM
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.